COMMONWEALTH OF AUSTRALIA
National Health Act 1953
PHARMACEUTICAL BENEFITS
DECLARATION UNDER SUBSECTION 85 (2AA)
No. PB 2 of 1996
I, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Human Services and Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:
1. This Declaration shall come into operation on 1 February 1996.
2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.
THE SCHEDULE
Etretinate
Neostigmine Bromide
Oxymetholone
Thioridazine
“XP Albumaid”
Dated this eleventh day of January 1996.
D. GRAHAM
Assistant Secretary
Pharmaceutical Benefits Branch
Department of Human Services and Health
Delegate of the Minister for Human Services and Health